Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for the treatment of secondary plasma cell leukemia.

Authors :: Jimenez-Zepeda, Victor H.
Reece, Donna E.
Trudel, Suzanne
Chen, Christine
Tiedemann, Rodger
Kukreti, Vishal
Source :: Leukemia & Lymphoma; Jan2015, Vol. 56 Issue 1, p232-235, 4p
Publication Year :: 2015
Abstract: A letter to the editor in response to the article "Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for the treatment of secondary plasma cell leukemia," that was published in a previous issue of the journal is presented.

Full Text Access

Tools